Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)

Summary

The objectives of this study are to determine the safety and efficacy in seasonal allergic rhinitis of a four-week course of mometasone furoate compared to beclomethasone dipropionate or placebo.

Timeline

Start

1993-08-23

Primary completion

1993-10-08

Completion

1993-10-22

Outcome

Met primary endpoint

registry analysis (other test); Mometasone Furoate (MF) vs Placebo; p <0.01; ANOVA NCT03855189 ↗

Drugs

Indications